Treatment of severe Crohn's disease with anti-CD4 monoclonal antibody

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 5, 1996, Pages 721-727

  Canva Delcambre, V ^a   Jacquot, S ^b   Robinet, E ^c   Lemann M ^b   Drouet, C ^a   Labalette, M ^d   Dessaint, J P ^d   Bengoufa, D ^b   Rabian, C ^b   Modigliani, R ^b   Wijdenes, J ^e   Revillard, J P ^c   Colombel, J F ^a,f  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIV LILLE   (France)

^e Laboratoire Diaclone   (France)

^f Clin Maladies l'Appareil Digestif   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG TOLERANCE; DYSPNEA; ENTERITIS; FEMALE; FEVER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; TACHYCARDIA;

EID: 0029798204     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.59201000.x     Document Type: Article

References (30)

1. Zeitz M. Immunoregulatory abnormalities in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1990; 2: 246-50.
2. Strober W, James SP. The immunologic basis of inflammatory bowel disease. J Clin Immunol 1986; 6: 415-32.
3. MacDermott RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin N Am 1994; 78: 1207-31.
4. Debinski HS, Kamm MA. Novel drug therapies in inflammatory bowel disease. Eur J Gastroenterol 1995; 7: 169-81 (Abstract).
5. Emmrich JS, Seyfarth M, Fleig WE, Emmrich F. Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Lancet 1991; ii: 570-1.
6. Deusch K, Mauthe B, Reiter C, Riethmüller G, Classen M. CD4 antibody treatment of inflammatory bowel disease: one year follow-up. Gastroenterology 1993; 104: A691 (Abstract).
7. Riethmüller G, Rieber EP, Kiefersauer S, et al. From anti-lymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease. Immunol Rev 1992; 129: 81-104.
8. Stronkhorst A, Radema S, Ten Berge I, et al. Phase 1 multiple-dose pilot study of chimeric monoclonal M-T412 (anti-CD4) antibodies in Crohn's disease. Gastroenterology 1993; 104: A784 (Abstract).
9. Herzog C, Walker C, Pichler W, et al. Monoclonal anti-CD4 in arthritis. Lancet 1987; ii: 1461-2.
10. Herzog C, Walker C, Muller W, et al. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun 1989; 2: 627-42.
11. Goldberg D, Morel P, Chatenoud L, et al. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J Autoimmun 1991; 4: 617-30.
12. Horneff G, Burmester GR, Emmrich F, Kalden JR. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 1991; 34: 129-40.
13. Wendling D, Widjenes J, Racadot E, Morel-Fourrier B. Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J Rheumatol 1991; 18: 325-7.
14. Wendling D, Racadot E, Morel-Fourrier B, Widjenes J. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone. Clin Rheumatol 1992; 11: 542-7.
15. Herve P, Racadot E, Wendling D, et al. Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience. Immunol Rev 1992; 129: 31-55.
16. Hafler DA, Ritz J, Schlossman ST, Weiner HL. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. J Immunol 1988; 141: 131-8.
17. Racadot E, Rumbach L, Bataillard M, et al. Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients. J Autoimmun 1993; 6: 771-86.
18. Morel P, Revillard JP, Nicolas JF, et al. Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmun 1992; 5: 465-77.
19. Best WR, Becktel JM, Singleton JW, Kern F. Development of Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
20. Morel P, Vincent C, Wijdenes J, Revillard JP. Internalization and degradation of anti-CD4 monoclonal antibodies bound to human peripheral blood lymphocytes. Mol Immunol 1993; 30: 649-57.
21. Robinet E, Stamm C, Morel P, et al. Clinical improvement of a patient with severe psoriasis following CD4 antibody administration despite blocking antibody host response. Eur J Dermatol 1996; 6: 141-6.
22. Jaffers GJ, Fuller TC, Cosimi AB, et al. Monoclonal antibody therapy: anti-idiotypic and non-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation 1985; 41: 572-8.
23. Chatenoud L, Baudrihaye MF, Chkoff N, et al. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3. J Immunol 1986; 137: 830-8.
24. Abramowicz D, Crusiaux A, Goldman M. Anaphylactic shock after retreatment with OKT3 monoclonal antibody. N Engl J Med 1992; 327: 736.
25. Choy EHS, Chikanza IC, Kingsley GH, Corrigal V, Panayi GS. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimeric anti-CD4 monoclonal antibody. Scand J Immunol 1992; 36: 291-8.
26. Vincent C, Fournel S, Wijdenes J, Revillard JP. Specific hyporesponsiveness of alloreactive peripheral T cells induced by CD4 antibodies. Eur J Immunol 1995; 25: 816-22.
27. Stronkhorst A, Yong SL, ten Berge I, et al. Modulation of the immune system with CD4 antibodies in Crohn's disease. Gastroenterology 1994; 104: A784.
28. Morel P, Nicolas JF, Wijdenes J, Revillard JP. Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibody. Clin Immunol Immunopath 1992; 64: 248-53.
29. Robinet E, Morel P, Assossou O, Revillard JP. TNF-α production as an in vitro assay predictive of cytokine-mediated toxic reactions induced by monoclonal antibodies. Toxicology 1995; 100: 213-23.
30. Reiter C, Kakavand B, Rieber EP, et al. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Arthritis Rheum 1991; 34: 525-36.